Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study.
about
Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trialsVitamin D status and cause-specific mortality: a general population studyVitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United StatesIs dietary fat, vitamin D, or folate associated with pancreatic cancer?Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomesPre-diagnostic circulating vitamin D and risk of melanoma in menAgreement of blood spot card measurements of vitamin D levels with serum, whole blood specimen types and a dietary recall instrumentSerum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control studySerum vitamin D, vitamin D binding protein, and risk of colorectal cancerVitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study.Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines.25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) studySerum vitamin D, vitamin D binding protein, and lung cancer survivalAn ecological study of cancer incidence and mortality rates in France with respect to latitude, an index for vitamin D production.Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening TrialPlasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany studyCirculating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps.Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men.Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.Vitamin D status in relation to glucose metabolism and type 2 diabetes in septuagenarians.Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study)Vitamin D deficiency and anthropometric indicators of adiposity in school-age children: a prospective study.Vitamin D status and chronic obstructive pulmonary disease: a prospective general population study.Hip fractures and bone mineral density in the elderly--importance of serum 25-hydroxyvitamin DRelationship of maternal vitamin D level with maternal and infant respiratory diseaseSerum 25 hydroxyvitamin D, bone mineral density and fracture risk across the menopause.Tightrope Walking: Using Predictors of 25(OH)D Concentration Based on Multivariable Linear Regression to Infer Associations with Health RisksThe vitamin D pathway and mammographic breast density among postmenopausal womenVitamin D as a Resilience Factor, Helpful for Survival of Potentially Fatal Conditions: A Hypothesis Emerging from Recent Findings of the ESTHER Cohort Study and the CHANCES Consortium.Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study.Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study.Association of 25-Hydroxyvitamin D status and genetic variation in the vitamin D metabolic pathway with FEV1 in the Framingham Heart StudyStaphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin StudyVitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study.Rising trend in vitamin D status from 1993 to 2013: dual concerns for the future.Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø StudyThe influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohortsVitamin D deficiency and age at menarche: a prospective study.
P2860
Q21089763-02619681-19E3-4C38-B62D-2BCF5D36B170Q21133789-DD2AA424-2BAD-4BD6-9743-3D3FF18FD52EQ22306553-9256FD82-B7A2-4E22-A6F6-6E812EF3F54AQ26851126-A2229F0A-A2EA-4315-9CFF-74CC6EB152B4Q28705618-FFDDF25A-ED9B-45CB-ACA1-4263B2AEFB5DQ28730259-FFC1DEC9-5B82-488E-B512-344225D2A069Q28743134-6E807F87-BAFF-4A03-A06D-8D10FF815442Q28743755-F0AC580B-75AD-4E52-A5AD-FB060717A390Q33921538-2DA11938-2121-4A11-AE11-B31637BA773AQ33969073-48E564D7-67C6-495F-885E-A47F72E28D25Q34235424-DED7E70F-568A-4149-BE5C-A55D0E2F115DQ34324553-1306970E-4B84-4F08-B1EC-6755190FA597Q34713803-FA08C2DE-B320-4BBB-A8BA-10F77993D9C2Q34847212-990D6AF6-2406-431B-B44A-F91EE9A877C4Q34898979-6E215892-E1CE-4FA2-B46C-5BCC9C123FD3Q34919132-C14CFAF0-BB75-4E10-B29E-5369D7B5A31EQ35000205-B596575B-733A-4CB6-A3AA-8698C7870657Q35017919-6A1E8D96-F525-496C-89F0-3D36275A838CQ35036628-F2D9EFF7-CF29-4B51-B233-BAC9901AF85EQ35043276-52AA912F-0CF7-49DA-BF9C-C6BC3EEF9B36Q35043732-6912F367-D547-4E8B-BDD7-3A45DF7F1EA5Q35092493-CC99FB3B-8B5D-405C-95A3-01F587713925Q35110706-D929C186-21D5-4236-B8D4-A7287666284AQ35118628-896F1912-0671-40A1-BCFA-CC5A0EBFB70BQ35209521-B8D988F3-EFB0-4ECB-8CEF-7A007741DA10Q35578316-624121E8-8DDD-4E32-81CF-E0B8991D357CQ35643641-30C4B556-4B5C-4513-8370-083A0464613BQ35650561-227AE4E5-EAED-4600-962E-92341CDB94D8Q35658055-386AE72C-CCEC-4A30-9A73-766CEBB60D2FQ35747212-D1AB090E-3AAB-4CDB-9379-B91CC903F323Q35803333-A800A614-1910-42E0-8A29-ACE0B68BF0E8Q35816927-C9233B8A-D5FB-4E92-BA26-5B2E022D5518Q35828220-F8F67DAA-CC0C-4E75-935B-BFB2621C6C6DQ35832595-854B79A3-924F-4201-9A15-4A30EECF70C1Q35833578-6F24801D-4E15-4E26-A33D-9DD625919955Q35877398-3826AD12-B311-4305-8388-331B7D407261Q35883514-73C3ABD5-B6E7-4711-94AE-E41E4AD1A7C3Q35898186-EED05A3F-3AAF-4C78-A62E-7DC23891E6E2Q35942077-CEBA1DBB-EE1C-44AA-A577-43D189A96A05Q35988892-A12C302F-85E2-48A9-BE57-3E40C502C0C3
P2860
Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Tracking of serum 25-hydroxyvi ...... nths in an intervention study.
@en
Tracking of serum 25-hydroxyvi ...... nths in an intervention study.
@nl
type
label
Tracking of serum 25-hydroxyvi ...... nths in an intervention study.
@en
Tracking of serum 25-hydroxyvi ...... nths in an intervention study.
@nl
prefLabel
Tracking of serum 25-hydroxyvi ...... nths in an intervention study.
@en
Tracking of serum 25-hydroxyvi ...... nths in an intervention study.
@nl
P2093
P2860
P356
P1476
Tracking of serum 25-hydroxyvi ...... onths in an intervention study
@en
P2093
Guri Grimnes
Moira Hutchinson
Nina Emaus
Rolf Jorde
Yngve Figenschau
P2860
P304
P356
10.1093/AJE/KWQ005
P407
P50
P577
2010-03-10T00:00:00Z